GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (TSX:OGI) » Definitions » Cash Conversion Cycle

OrganiGram Holdings (TSX:OGI) Cash Conversion Cycle : 198.13 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is OrganiGram Holdings Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

OrganiGram Holdings's Days Sales Outstanding for the three months ended in Dec. 2024 was 78.15.
OrganiGram Holdings's Days Inventory for the three months ended in Dec. 2024 was 294.23.
OrganiGram Holdings's Days Payable for the three months ended in Dec. 2024 was 174.25.
Therefore, OrganiGram Holdings's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2024 was 198.13.


OrganiGram Holdings Cash Conversion Cycle Historical Data

The historical data trend for OrganiGram Holdings's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings Cash Conversion Cycle Chart

OrganiGram Holdings Annual Data
Trend Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 757.31 211.02 214.92 171.70 189.48

OrganiGram Holdings Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.00 205.40 205.66 193.27 198.13

Competitive Comparison of OrganiGram Holdings's Cash Conversion Cycle

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganiGram Holdings's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's Cash Conversion Cycle falls into.


;
;

OrganiGram Holdings Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

OrganiGram Holdings's Cash Conversion Cycle for the fiscal year that ended in Sep. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=87.36+245.04-142.92
=189.48

OrganiGram Holdings's Cash Conversion Cycle for the quarter that ended in Dec. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=78.15+294.23-174.25
=198.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrganiGram Holdings  (TSX:OGI) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


OrganiGram Holdings Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


OrganiGram Holdings Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds brands, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
Executives
Paolo De Luca Senior Officer
Dexter John Director
Katrina May Mcfadden Senior Officer
Donald Geoffrey Machum Director
Stephen A. Smith Director
Derrick West Senior Officer
Sherry Porter Director
Michel Bourque Director
Kenneth Arnold Mitton Director
Denis Joseph Robert Arsenault 10% Security Holder, Director, Senior Officer